Choroideremia
Rare Disease·MeSH: Choroideremia
Prevalence
5.0 / 100K
3 drugs in development·3 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nsr-rep1 | Nightstar Therapeutics plc (NITE) |
Phase 1(1)
| Drug | Company |
|---|---|
| 4D-110 | 4D Molecular Therapeutics, Inc. (FDMT) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| spk-7001 | Spark Therapeutics, Inc. (SPARK) |
Compare drugs
Frequently asked questions
How many drugs are in development for Choroideremia?
BioSniper tracks 3 drugs in development for Choroideremia across 3 companies.
How many clinical trials target Choroideremia?
There are 2 clinical trials targeting Choroideremia tracked by BioSniper.
What is the prevalence of Choroideremia?
The estimated prevalence of Choroideremia is approximately 5.0 per 100,000 population.
Deep-dive into Choroideremia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis